Search research articles
Contact Us
Filters
Showing results (301-310 of 446) with videos related to
Page
of 45
Sort By:
NPJ Biofilms and Microbiomes
|
January 21, 2026
Profound taxonomic and functional gut microbiota alterations associated with trichuriasis: cross-country and country-specific patterns
Pierre H H Schneeberger, Julian Dommann, Nurudeen Rahman, et al.
Chemmedchem
|
December 16, 2024
Synthesis of 1,2,3-Triazole-Methyl-Menadione Derivatives: Evaluation of Electrochemical and Antiparasitic Properties against two Blood-Dwelling Parasites
Baptiste Dupouy, Tanja Karpstein, Cécile Häberli, et al.
The Lancet. Infectious Diseases
|
September 22, 2015
Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study
Wendelin Moser, Said M Ali, Shaali M Ame, et al.
Journal of Medicinal Chemistry
|
November 14, 2013
In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives
Malay Patra, Katrin Ingram, Anna Leonidova, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2022
Antischistosomal tetrahydro-γ-carboline sulfonamides
Rongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Biotechnology Advances
|
March 10, 2022
Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery
H M P Dilrukshi Herath, Aya C Taki, Ali Rostami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 31, 2010
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial
Jennifer Keiser, Nicaise A N'Guessan, Koffi D Adoubryn, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2010
Praziquantel analogs with activity against juvenile Schistosoma mansoni
Yuxiang Dong, Jacques Chollet, Mireille Vargas, et al.
NPJ Biofilms and Microbiomes
|
May 28, 2026
Combined high-quality metagenomics reveals off-target effects of albendazole, ivermectin-albendazole and moxidectin-albendazole on the human gut bacteria
Julian Dommann, Viviane P Sprecher, Christian Beisel, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2011
In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes
Britta Stadelmann, Tatiana Küster, Sabrina Scholl, et al.
Page
of 45
Search research articles
Search
Showing results (301-310 of 446) with videos related to
Sort By:
Page
of 45
NPJ Biofilms and Microbiomes
|
January 21, 2026
Profound taxonomic and functional gut microbiota alterations associated with trichuriasis: cross-country and country-specific patterns
Pierre H H Schneeberger, Julian Dommann, Nurudeen Rahman, et al.
Chemmedchem
|
December 16, 2024
Synthesis of 1,2,3-Triazole-Methyl-Menadione Derivatives: Evaluation of Electrochemical and Antiparasitic Properties against two Blood-Dwelling Parasites
Baptiste Dupouy, Tanja Karpstein, Cécile Häberli, et al.
The Lancet. Infectious Diseases
|
September 22, 2015
Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study
Wendelin Moser, Said M Ali, Shaali M Ame, et al.
Journal of Medicinal Chemistry
|
November 14, 2013
In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives
Malay Patra, Katrin Ingram, Anna Leonidova, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2022
Antischistosomal tetrahydro-γ-carboline sulfonamides
Rongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Biotechnology Advances
|
March 10, 2022
Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery
H M P Dilrukshi Herath, Aya C Taki, Ali Rostami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 31, 2010
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial
Jennifer Keiser, Nicaise A N'Guessan, Koffi D Adoubryn, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2010
Praziquantel analogs with activity against juvenile Schistosoma mansoni
Yuxiang Dong, Jacques Chollet, Mireille Vargas, et al.
NPJ Biofilms and Microbiomes
|
May 28, 2026
Combined high-quality metagenomics reveals off-target effects of albendazole, ivermectin-albendazole and moxidectin-albendazole on the human gut bacteria
Julian Dommann, Viviane P Sprecher, Christian Beisel, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2011
In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes
Britta Stadelmann, Tatiana Küster, Sabrina Scholl, et al.
Page
of 45